Table 3 Echocardiography in the 11 patients included in the data set analysis
From: Impact of High-Intensity-NIV on the heart in stable COPD: a randomised cross-over pilot study
Patient ID | SV (ml) | CO (l/min) | CI (l/min/m2) | LV diastolic | sPAP (mmHg) | RVb (cm) | FAC (%) | TAPSE (mm) | S` (cm/s) |
|---|---|---|---|---|---|---|---|---|---|
1 | |||||||||
 Baseline | 53 | 5.3 | 2.3 | normal (E/A 0.8) | 33 | 4.2 | 59 | 14 | 10 |
 LI-NIVSB, (NIV) | 63 (57) | 5.1 (5.7) | 2.2 (2.1) |  | na | 4.3 | 55 | 18 | 10 |
 HI-NIV SB (NIV) | 87 (74) | 7.0 (5.6) | 3.1 (2.4) |  | na | 4.0 | 47 | 17 | 15 |
2 | |||||||||
 Baseline | 56 | 4.6 | 2.7 | normal (E/A 0.9) | na | 3.6 | 44 | 16 | 11 |
 LI-NIV SB (NIV) | 72 | 5.5 (5.9) | 3.2 (3.4) |  | na | 3.7 | 50 | 11 | 12 |
 HI-NIV SB (NIV) | 65 | 4.8 (6.3) | 2.8 (3.6) |  | na | 4.2 | 45 | 15 | 17 |
3 | |||||||||
  Baseline | 54 | 4.9 | 2.8 | normal (E/A 1.2) | na | 3.9 | 57 | 16 | 15 |
  HI-NIV SB (NIV) | 64 (56) | 5.9 (6.2) | 3.3 (3.5) |  | na | 3.5 | 60 | 21 | 10 |
  LI-NIV SB (NIV) | 63 (72) | 5.3 (6.3) | 3.0 (3.6) |  | na | 3.0 | 50 | 17 | 11 |
4 | |||||||||
 Baseline | 72 | 6.9 | 3.8 | normal (E/A 1.1) | na | 2.5 | 70 | 16 | 17 |
 LI-NIV SB (NIV) | 66 (68) | 5.8 (5.3) | 3.3 (3.1) |  | na | 3.2 | 66 | 19 | 10 |
 HI-NIV SB (NIV) | 73 (75) | 7.5 (7.7) | 4.3 (4.4) |  | na | na | na | 19 | 12 |
5 | |||||||||
 Baseline | 53 | 4.4 | 1.8 | restrictive,MV E Vmax 120 cm/s | na | 5.4 | 41 | 20 | na |
 HI-NIV SB (NIV) | 77 (89) | 4.9 (5.6) | 2.0 (2.3) |  | 29 | 3.7 | 20 | 15 | 10 |
 LI-NIV SB (NIV) | 104 (75) | 7.8 (6.5) | 3.2 (2.7) |  | 18 | 4.2 | na | 18 | na |
6 | |||||||||
 Baseline | 60 | 5.0 | 2.9 | normal (E/A 0.7) | 43 | 4.2 | 50 | 20 | 10 |
 HI-NIV SB (NIV) | 56 (na) | 4.0 (na) | 2.3 (na) |  | 23 | 4.2 | 53 | 23 | 14 |
 LI-NIV SB (NIV) | 92 (na) | 6.0 (na) | 3.4 (na) |  | 44 | 4.1 | 45 | 22 | 11 |
7 | |||||||||
  Baseline | 43 | 4.3 | 2.4 | MV E Vmax 80 cm/s | 46 | 4.2 |  | 11 | 8 |
  LI-NIV SB (NIV) | 50 (57) | 3.4 (4.1) | 1.9 (2.3) |  | 37 | 3.8 |  | 11 | na |
  HI-NIV SB (NIV) | 45 (50) | 3.9 (4.5) | 2.2 (2.5) |  | 31 | 4.5 |  | 13 | 10 |
8 | |||||||||
 Baseline | 67 | 5.7 | 3,9 | normal (E/A 0.8) | 33 | 2.7 | 45 | 17 | 12 |
 LI-NIV SB (NIV) | 66 (68) | 5.2 (5.2) | 3.5 (3.5) |  | 36 | 2.9 | 50 | 17 | 18 |
 HI-NIV SB (NIV) | 56 (52) | 4.6 (4.2) | 3.2 (2.9) |  | 36 | 2.9 | 44 | 21 | 10 |
9 | |||||||||
 Baseline | 90 | 7.6 | 4,8 | normal (E/A 0.9) | na | na | na | na | na |
 LI-NIV SB (NIV) | 85 (74) | 6.9 (5.3) | 4.4 (3.4) |  | 26 | 4.2 | 41 | 18 | 16 |
 HI-NIV SB (NIV) | 76 (67) | 6.2 (5.5) | 3.9 (3.5) |  | 30 | 3.7 | 59 | 19 | 14 |
10 | |||||||||
  Baseline | 79 | 6.3 | 3.8 | normal (E/A 0.9) | na | 3.4 | 70 | 15 | 16 |
  HI-NIV SB (NIV) | 84 (69) | 4.9 (4.1) | 2.8 (2.3) |  | na | 3.9 | na | 21 | 10 |
  LI-NIV SB (NIV) | 86 (83) | 5.4 (5.3) | 3.1 (3.0) |  | 23 | 3.6 | 48 | 16 | 10 |
11 | |||||||||
  Baseline | 78 | 4.9 | 2.9 | normal (E/A 0.7) | 34 | 3.2 | 60 | 15 | 15 |
  HI-NIV SB (NIV) | 52 (57) | 3.0 (3.4) | 1.8 (2.0) |  | na | 3.8 | 40 | 23 | 12 |
  LI-NIV SB (NIV) | 59 (58) | 4.8 (4.0) | 2.9 (2.4) |  | 25 | 3.7 | 65 | 25 | 12 |
12 | |||||||||
  Baseline | 86 | 6.8 | 3.8 | normal (E/A 0.9) | 24 | 4.4 |  | 20 | 12 |
  HI-NIV SB (NIV) | 81 (68) | 6.9 (6.4) | 3.8 (3.6) |  | 21 | 4.1 |  | 25 | 18 |
13 | |||||||||
  Baseline | 56 | 4.8 | 3.3 | normal (E/A 1.4) | 39 | 2.5 |  | 13 | 16 |
  HI-NIV SB (NIV) | 47 (35) | 4.1 (3.1) | 2.9 (2.2) |  | 43 | 3.1 |  | 21 | 11 |
14 | |||||||||
 Baseline | 68 | 4.8 | 3.4 | normal (E/A 0.7) | na | 3.1 | 47 | 18 | 16 |
 LI-NIV SB (NIV) | 61 (60) | 3.5 (3.4) | 2.5 (2.4) |  | 29 | 3.0 | 50 | 18 | 12 |
 HI-NIV SB (NIV) | 70 (71) | 5.3 (4.7) | 3.7 (3.3) |  | 28 | 2.8 | 52 | 14 | 14 |